Sidath Liyanage
UCL Institute of Ophthalmology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sidath Liyanage.
PLOS ONE | 2013
Colin Chu; Philipp Herrmann; Livia S. Carvalho; Sidath Liyanage; James W. Bainbridge; Robin R. Ali; Andrew D. Dick; Ulrich F.O. Luhmann
Despite advances in clinical imaging and grading our understanding of retinal immune responses and their morphological correlates in experimental autoimmune uveoretinitis (EAU), has been hindered by the requirement for post-mortem histology. To date, monitoring changes occurring during EAU disease progression and evaluating the effect of therapeutic intervention in real time has not been possible. We wanted to establish whether optical coherence tomography (OCT) could detect intraretinal changes during inflammation and to determine its utility as a tool for accurate scoring of EAU. EAU was induced in C57BL/6J mice and animals evaluated after 15, 26, 36 and 60 days. At each time-point, contemporaneous Spectralis-OCT scanning, topical endoscopic fundal imaging (TEFI), fundus fluorescein angiography (FFA) and CD45-immunolabelled histology were performed. OCT features were further characterised on retinal flat-mounts using immunohistochemistry and 3D reconstruction. Optic disc swelling and vitreous opacities detected by OCT corresponded to CD45+ cell infiltration on histology. Vasculitis identified by FFA and OCT matched perivascular myeloid and T-cell infiltrates and could be differentiated from unaffected vessels. Evolution of these changes could be followed over time in the same eye. Retinal folds were visible and found to encapsulate mixed populations of activated myeloid cells, T-cells and microglia. Using these features, an OCT-based EAU scoring system was developed, with significant correlation to validated histological (Pearson r2 = 0.6392, P<0.0001, n = 31 eyes) and TEFI based scoring systems (r2 = 0.6784, P<0.0001). OCT distinguishes the fundamental features of murine EAU in vivo, permits dynamic assessment of intraretinal changes and can be used to score disease severity. As a result, it allows tissue synchronisation with subsequent cellular and functional assessment and greater efficiency of animal usage. By relating OCT signals with immunohistochemistry in EAU, our findings offer the opportunity to inform the interpretation of OCT changes in human uveitis.
Neurobiology of Aging | 2015
Philipp Herrmann; Jill A. Cowing; Enrico Cristante; Sidath Liyanage; Joana Ribeiro; Yanai Duran; Laura Abelleira Hervás; Livia S. Carvalho; James W. Bainbridge; Ulrich F.O. Luhmann; Robin R. Ali
Dysregulation of the complement system has been implicated in the pathogenesis of age-related macular degeneration. To investigate consequences of altered complement regulation in the eye with age, we examined Cd59a complement regulator deficient (Cd59a(-/-)) mice between 4 and 15 months. In vivo imaging revealed an increased age-related accumulation of autofluorescent spots in Cd59a(-/-) mice, a feature that reflects accumulation of subretinal macrophages and/or microglia. Despite this activation of myeloid cells in the eye, Cd59a(-/-) mice showed normal retinal histology and function as well as normal choroidal microvasculature. With age, they revealed increased expression of activators of the alternative complement pathway (C3, Cfb, Cfd), in particular in the retinal pigment epithelium (RPE)-choroid but less in the retina. This molecular response was not altered by moderately-enhanced light exposure. Cd59a deficiency therefore leads to a preferential age-related dysregulation of the complement system in the RPE-choroid, that alone or in combination with light as a trigger, is not sufficient to cause choroidal vascular changes or retinal degeneration and dysfunction. This data emphasizes the particular vulnerability of the RPE-choroidal complex to dysregulation of the alternative complement pathway during aging.
Disease Models & Mechanisms | 2016
Colin Chu; Peter J. Gardner; David A. Copland; Sidath Liyanage; Anai Gonzalez-Cordero; Sophia-Martha kleine Holthaus; Ulrich F.O. Luhmann; Alexander J. Smith; Robin R. Ali; Andrew D. Dick
ABSTRACT Endotoxin-induced uveitis (EIU) in rodents is a model of acute Toll-like receptor 4 (TLR4)-mediated organ inflammation, and has been used to model human anterior uveitis, examine leukocyte trafficking and test novel anti-inflammatory therapeutics. Wider adoption has been limited by the requirement for manual, non-specific, cell-count scoring of histological sections from each eye as a measure of disease severity. Here, we describe a comprehensive and efficient technique that uses ocular dissection and multimodal tissue analysis. This allows matched disease scoring by multicolour flow cytometric analysis of the inflammatory infiltrate, protein analysis on ocular supernatants and qPCR on remnant tissues of the same eye. Dynamic changes in cell populations could be identified and mapped to chemokine and cytokine changes over the course of the model. To validate the technique, dose-responsive suppression of leukocyte infiltration by recombinant interleukin-10 was demonstrated, as well as selective suppression of the monocyte (CD11b+Ly6C+) infiltrate, in mice deficient for either Ccl2 or Ccr2. Optical coherence tomography (OCT) was used for the first time in this model to allow in vivo imaging of infiltrating vitreous cells, and correlated with CD11b+Ly6G+ counts to provide another unique measure of cell populations in the ocular tissue. Multimodal tissue analysis of EIU is proposed as a new standard to improve and broaden the application of this model. Summary: A refined platform approach for endotoxin-induced uveitis, using multimodal ex vivo and in vivo assessment, to improve quantification and phenotyping in this ocular model of compartmentalised tissue inflammation.
Arteriosclerosis, Thrombosis, and Vascular Biology | 2016
Sidath Liyanage; Alessandro Fantin; Pilar Villacampa; Clemens A. Lange; Laura Denti; Enrico Cristante; Alexander J. Smith; Robin R. Ali; Ulrich F.O. Luhmann; James W. Bainbridge; Christiana Ruhrberg
Objective— Ocular neovascularization (ONV) is a pathological feature of sight-threatening human diseases, such as diabetic retinopathy and age-related macular degeneration. Macrophage depletion in mouse models of ONV reduces the formation of pathological blood vessels, and myeloid cells are widely considered an important source of the vascular endothelial growth factor A (VEGF). However, the importance of VEGF or its upstream regulators hypoxia-inducible factor-1&agr; (HIF1&agr;) and hypoxia-inducible factor-2&agr; (HIF2&agr;) as myeloid-derived regulators of ONV remains to be determined. Approach and Results— We used 2 mouse models of ONV, choroidal neovascularization and oxygen-induced retinopathy, to show that Vegfa is highly expressed by several cell types, but not myeloid cells during ONV. Moreover, myeloid-specific VEGF ablation did not reduce total ocular VEGF during choroidal neovascularization or oxygen-induced retinopathy. In agreement, the conditional inactivation of Vegfa, Hif1a, or Epas1 in recruited and resident myeloid cells that accumulated at sites of neovascularization did not significantly reduce choroidal neovascularization or oxygen-induced retinopathy. Conclusions— The finding that myeloid cells are not a significant local source of VEGF in these rodent models of ONV suggests that myeloid function in neovascular eye disease differs from skin wound healing and other neovascular pathologies.
Experimental Eye Research | 2016
Sidath Liyanage; Peter J. Gardner; Joana Ribeiro; Enrico Cristante; Robert D. Sampson; Ulrich F.O. Luhmann; Robin R. Ali; James W. Bainbridge
Myeloid cells make a pivotal contribution to tissue homeostasis during inflammation. Both tissue-specific resident populations and infiltrating myeloid cells can cause tissue injury through aberrant activation and/or dysregulated activity. Reliable identification and quantification of myeloid cells within diseased tissues is important to understand pathological inflammatory processes. Flow cytometry is a valuable technique for leukocyte analysis, but a standardized flow cytometric method for myeloid cell populations in the eye is lacking. Here, we validate a reproducible flow cytometry gating approach to characterize myeloid cells in several commonly used models of ocular inflammation. We profile and quantify myeloid subsets across these models, and highlight the value of this strategy in identifying phenotypic differences using Ccr2-deficient mice. This method will aid standardization in the field and facilitate future investigations into the roles of myeloid cells during ocular inflammation.
Journal of Experimental Medicine | 2017
Alessandro Fantin; Anastasia Lampropoulou; Valentina Senatore; James T. Brash; Claudia Prahst; Clemens A. Lange; Sidath Liyanage; Claudio Raimondi; James W. Bainbridge; Hellmut G. Augustin; Christiana Ruhrberg
The vascular endothelial growth factor (VEGF) isoform VEGF165 stimulates vascular growth and hyperpermeability. Whereas blood vessel growth is essential to sustain organ health, chronic hyperpermeability causes damaging tissue edema. By combining in vivo and tissue culture models, we show here that VEGF165-induced vascular leakage requires both VEGFR2 and NRP1, including the VEGF164-binding site of NRP1 and the NRP1 cytoplasmic domain (NCD), but not the known NCD interactor GIPC1. In the VEGF165-bound receptor complex, the NCD promotes ABL kinase activation, which in turn is required to activate VEGFR2-recruited SRC family kinases (SFKs). These results elucidate the receptor complex and signaling hierarchy of downstream kinases that transduce the permeability response to VEGF165. In a mouse model with choroidal neovascularisation akin to age-related macular degeneration, NCD loss attenuated vessel leakage without affecting neovascularisation. These findings raise the possibility that targeting NRP1 or its NCD interactors may be a useful therapeutic strategy in neovascular disease to reduce VEGF165-induced edema without compromising vessel growth.
Scientific Reports | 2017
Peter J. Gardner; Sidath Liyanage; Enrico Cristante; Robert D. Sampson; Andrew D. Dick; Robin R. Ali; James W. Bainbridge
Hypoxia inducible factors (HIFs) are ubiquitously expressed transcription factors important for cell homeostasis during dynamic oxygen levels. Myeloid specific HIFs are crucial for aspects of myeloid cell function, including their ability to migrate into inflamed tissues during autoimmune disease. This contrasts with the concept that accumulation of myeloid cells at ischemic and hypoxic sites results from a lack of chemotactic responsiveness. Here we seek to address the role of HIFs in myeloid trafficking during inflammation in a mouse model of human uveitis. We show using mice with myeloid-specific Cre-deletion of HIFs that myeloid HIFs are dispensable for leukocyte migration into the inflamed eye. Myeloid-specific deletion of Hif1a, Epas1, or both together, had no impact on the number of myeloid cells migrating into the eye. Additionally, stabilization of HIF pathways via deletion of Vhl in myeloid cells had no impact on myeloid trafficking into the inflamed eye. Finally, we chemically induce hypoxemia via hemolytic anemia resulting in HIF stabilization within circulating leukocytes to demonstrate the dispensable role of HIFs in myeloid cell migration into the inflamed eye. These data suggest, contrary to previous reports, that HIF pathways in myeloid cells during inflammation and hypoxia are dispensable for myeloid cell tissue trafficking.
Disease Models & Mechanisms | 2015
Dawn A. Sim; Colin Chu; Senthil Selvam; Michael B. Powner; Sidath Liyanage; David A. Copland; Pearse A. Keane; Adnan Tufail; Catherine Egan; James W. Bainbridge; Richard W J Lee; Andrew D. Dick; Marcus Fruttiger
ABSTRACT We have developed a method to label and image myeloid cells infiltrating the mouse retina and choroid in vivo, using a single depot injection of indocyanine green dye (ICG). This was demonstrated using the following ocular models of inflammation and angiogenesis: endotoxin-induced uveitis, experimental autoimmune uveoretinitis and laser-induced choroidal neovascularization model. A near-infrared scanning ophthalmoscope was used for in vivo imaging of the eye, and flow cytometry was used on blood and spleen to assess the number and phenotype of labelled cells. ICG was administered 72 h before the induction of inflammation to ensure clearance from the systemic circulation. We found that in vivo intravenous administration failed to label any leukocytes, whereas depot injection, either intraperitoneal or subcutaneous, was successful in labelling leukocytes infiltrating into the retina. Progression of inflammation in the retina could be traced over a period of 14 days following a single depot injection of ICG. Additionally, bright-field microscopy, spectrophotometry and flow cytometric analysis suggest that the predominant population of cells stained by ICG are circulating myeloid cells. The translation of this approach into clinical practice would enable visualization of immune cells in situ. This will not only provide a greater understanding of pathogenesis, monitoring and assessment of therapy in many human ocular diseases but might also open the ability to image immunity live for neurodegenerative disorders, cardiovascular disease and systemic immune-mediated disorders. Summary: We show here that peripheral leukocytes can be labelled with ICG in vivo and then directly imaged as they invade the retina after inflammatory stimuli.
Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie | 2008
Neruban Kumaran; Sidath Liyanage; Romesh I. Angunawela; Riaz Hassan Yusuf Asaria
A24-year-old woman presented with a 2-day history of sudden, painless, blurred vision in her right eye. Best-corrected visual acuities were 20/30, improving to 20/15 with pinhole in the right eye and 20/15 in the left eye. Anterior segments, intraocular pressures, and the left fundus were normal. Right fundal examination revealed a swollen, hyperaemic optic disc with mildly tortuous and dilated retinal veins. A few flame-shaped hemorrhages were present in the inferior fundus, with no signs of inflammation or macular edema. A mild, inferior hemiretinal vein occlusion (HRVO) was diagnosed. General medical examination and results of investigations, including full blood count, erythrocyte sedimentation rate, C-reactive protein, serum electrophoresis, clotting screen, antinuclear antigens, extractable nuclear antigens, homocysteine levels, fasting glucose, and lipid screen, were normal. She was a nonsmoker with no relevant ocular, medical, obstetric, or drug history. One week later, her right visual acuity had deteriorated to 20/30 and examination showed a mild central retinal vein occlusion (CRVO), with hemorrhages in all 4 quadrants. Fundus fluorescein angiography discovered both a CRVO and cilioretinal artery occlusion (Fig. 1). Management was conservative, and follow-up 2 months later revealed complete resolution of both CRVO and cilioretinal artery occlusion, with a best-corrected visual acuity of 20/15. Controversy still exists regarding the pathogenesis of the simultaneous CRVO and cilioretinal artery occlusion, which was first described in 1968.1 Some authors claim independent obstruction; others suggest that cilioretinal artery occlusion occurs secondary to CRVO, when increased retinal venous pressure causes a relative hypoperfusion of the cilioretinal artery.2,3 This case supports the latter theory, as our patient presented 1 week earlier with signs of an inferior HRVO and no cilioretinal artery occlusion. The recognition of this phenomenon and its likely pathogenesis will reduce unnecessary investigation of this secondary arteriolar occlusion.4 Furthermore, visual deterioration in these individuals may be partly the result of superimposed subclinical cilioretinal hypoperfusion due to raised venous pressure. Although it has been postulated that lowering intraocular pressures has little effect on perfusion pressures in CRVOs,5 this likely pathogenesis suggests that this approach may benefit the cilioretinal hypoperfusion and consequently, vision, in this specific subset of patients.
Development | 2018
Enrico Cristante; Sidath Liyanage; Robert D. Sampson; Aikaterini Kalargyrou; Giulia De Rossi; Matteo Rizzi; Justin Hoke; Joana Ribeiro; Ryea N. Maswood; Yanai Duran; Takaaki Matsuki; Nozie D. Aghaizu; Ulrich F.O. Luhmann; Alexander J. Smith; Robin R. Ali; James W. Bainbridge
ABSTRACT In the adult central nervous system, endothelial and neuronal cells engage in tight cross-talk as key components of the so-called neurovascular unit. Impairment of this important relationship adversely affects tissue homeostasis, as observed in neurodegenerative conditions including Alzheimers and Parkinsons disease. In development, the influence of neuroprogenitor cells on angiogenesis is poorly understood. Here, we show in mouse that these cells interact intimately with the growing retinal vascular network, and we identify a novel regulatory mechanism of vasculature development mediated by hypoxia-inducible factor 2a (Hif2a). By Cre-lox gene excision, we show that Hif2a in retinal neuroprogenitor cells upregulates the expression of the pro-angiogenic mediators vascular endothelial growth factor and erythropoietin, whereas it locally downregulates the angiogenesis inhibitor endostatin. Importantly, absence of Hif2a in retinal neuroprogenitor cells causes a marked reduction of proliferating endothelial cells at the angiogenic front. This results in delayed retinal vascular development, fewer major retinal vessels and reduced density of the peripheral deep retinal vascular plexus. Our findings demonstrate that retinal neuroprogenitor cells are a crucial component of the developing neurovascular unit. Summary: Hypoxia-inducible factor 2a expressed in neuroprogenitors promotes angiogenesis in mouse retina by upregulating expression of vascular endothelial growth factor and erythropoietin, and downregulating endostatin.